IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
NOVIO's INO-3107 Achieves EMA Certification for Recurrent Respiratory Papillomatosis Treatment

NOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related disease...

July 26, 2024 | Friday | News
Inventiva Secures Japanese Patent for Lanifibranor in Cirrhosis Treatment

Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with met...

July 26, 2024 | Friday | News
Triastek and BioNTech Partner to Develop Innovative Oral RNA Therapeutics Using 3D Printing Technology

Triastek Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals,  announced that it has entered into a research collaboration and platfor...

July 25, 2024 | Thursday | News
GeneCentric Therapeutics Secures AMA PLA Code for AI-Driven PurIST Pancreatic Cancer Test

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that the American Medical Assoc...

July 25, 2024 | Thursday | News
Thermo Fisher Chairman Marc N. Casper Attributes Success to Proven Growth Strategy and Welcomes Olink Colleagues

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29...

July 24, 2024 | Wednesday | Company results
Lario Therapeutics Receives $6 Million Grant from MJFF for Innovative Parkinson’s Disease Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Par...

July 23, 2024 | Tuesday | News
Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...

July 19, 2024 | Friday | News
Shanghai Junshi Biosciences' sNDA for Toripalimab and Bevacizumab Combo for Advanced Liver Cancer Accepted by NMPA

  Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...

July 19, 2024 | Friday | News
Thermo Fisher Scientific Finalizes $3.1 Billion Acquisition of Olink, Ushering in a New Era in Proteomics

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, has announced the successful completion of ...

July 11, 2024 | Thursday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Myricx Bio Secures £90m Series A Funding Co-Led by Novo Holdings and Abingworth

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...

July 08, 2024 | Monday | News
Valneva's Single-Dose Chikungunya Vaccine, IXCHIQ®, Receives European Commission Approval

  Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...

July 01, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close